OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.240
-0.020 (-1.59%)
At close: May 9, 2025, 4:00 PM
1.260
+0.020 (1.61%)
After-hours: May 9, 2025, 7:54 PM EDT
OPKO Health Market Cap
OPKO Health has a market cap or net worth of $983.39 million as of May 9, 2025. Its market cap has increased by 14.71% in one year.
Market Cap
983.39M
Enterprise Value
1.05B
1-Year Change
14.71%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since December 1, 1998, OPKO Health's market cap has increased from $51.70M to $983.39M, an increase of 1,802.10%. That is a compound annual growth rate of 11.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 983.40M | -1.98% |
| Dec 31, 2024 | 1.00B | -14.05% |
| Dec 29, 2023 | 1.17B | 20.85% |
| Dec 30, 2022 | 965.90M | -70.53% |
| Dec 31, 2021 | 3.28B | 23.84% |
| Dec 31, 2020 | 2.65B | 170.49% |
| Dec 31, 2019 | 978.40M | -41.94% |
| Dec 31, 2018 | 1.69B | -38.52% |
| Dec 29, 2017 | 2.74B | -47.14% |
| Dec 30, 2016 | 5.19B | -5.34% |
| Dec 31, 2015 | 5.48B | 26.29% |
| Dec 31, 2014 | 4.34B | 25.95% |
| Dec 31, 2013 | 3.44B | 140.08% |
| Dec 31, 2012 | 1.43B | 0.84% |
| Dec 30, 2011 | 1.42B | 51.76% |
| Dec 31, 2010 | 937.20M | 101.81% |
| Dec 31, 2009 | 464.40M | 44.27% |
| Dec 31, 2008 | 321.90M | -30.80% |
| Dec 31, 2007 | 465.20M | 3,130.56% |
| Dec 29, 2006 | 14.40M | 108.70% |
| Dec 30, 2005 | 6.90M | 25.45% |
| Dec 31, 2004 | 5.50M | -60.99% |
| Dec 31, 2003 | 14.10M | 147.37% |
| Dec 31, 2002 | 5.70M | -89.42% |
| Dec 31, 2001 | 53.90M | -54.71% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |